{
  "1PG.MU": {
    "city": "Lysaker",
    "country": "Norway",
    "currency": "EUR",
    "exchange": "MUN",
    "industry": "Drug Manufacturers - Specialty & Generic",
    "long_name": "Aker BioMarine AS",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "AKER BIOMARINE ASA  NK 6",
    "state": null,
    "summary": "Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates in two segments, Ingredients and Brands. The company provides krill oil products, including omega-3s, phospholipids, choline, and astaxanthin under the Superba, Kori, NKO, and KÂ·REAL brands. It also offers Qrill aqua nutrient-rich feed ingredients for aquaculture; and QRILL pet, a functional ingredient for pet food. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste into products, such as shopping baskets and food trays. Aker BioMarine AS has an agreement with Medical Food Solutions Research to develop pharmaceutical therapies for brain and eye health based on Lysoveta. The company is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.",
    "website": "http://www.akerbiomarine.com",
    "zipcode": "1327"
  },
  "3Z6.F": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Drug Manufacturers - Specialty & Generic",
    "long_name": "NattoPharma ASA",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "NATTOPHARMA ASA  NK 3",
    "state": null,
    "summary": "As of March 23, 2021, NattoPharma ASA operates as a subsidiary of Compagnie Des Levures Lesaffre SA.",
    "website": "http://www.nattopharma.com",
    "zipcode": "0283"
  },
  "AKBM.OL": {
    "city": "Lysaker",
    "country": "Norway",
    "currency": "NOK",
    "exchange": "OSL",
    "industry": "Drug Manufacturers - Specialty & Generic",
    "long_name": "Aker BioMarine AS",
    "market": "no_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "AKER BIOMARINE ASA",
    "state": null,
    "summary": "Aker BioMarine AS develops, produces, and sells krill-derived ingredients for nutraceutical, dietary supplement, and animal feed applications in Norway, the Americas, the Asia Pacific, Europe, the Middle East, and Africa. It operates in two segments, Ingredients and Brands. The company provides krill oil products, including omega-3s, phospholipids, choline, and astaxanthin under the Superba, Kori, NKO, and KÂ·REAL brands. It also offers Qrill aqua nutrient-rich feed ingredients for aquaculture; and QRILL pet, a functional ingredient for pet food. The company also offers LYSOVETA, a delivery platform based on LPC-bound EPA and DHA from krill; and INVI, a hydrolyzed protein isolate for food and beverage applications. In addition, it distributes human health and nutrition products, and natural supplements, as well as provides AION, a circular solution provider that recycles waste into products, such as shopping baskets and food trays. Aker BioMarine AS has an agreement with Medical Food Solutions Research to develop pharmaceutical therapies for brain and eye health based on Lysoveta. The company is headquartered in Lysaker, Norway. Aker BioMarine ASA is a subsidiary of Aker ASA.",
    "website": "http://www.akerbiomarine.com",
    "zipcode": "1327"
  },
  "NATTO.OL": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "NOK",
    "exchange": "OSL",
    "industry": "Drug Manufacturers - Specialty & Generic",
    "long_name": "NattoPharma ASA",
    "market": "no_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "NATTOPHARMA ASA",
    "state": null,
    "summary": "As of March 23, 2021, NattoPharma ASA operates as a subsidiary of Compagnie Des Levures Lesaffre SA.",
    "website": "http://www.nattopharma.com",
    "zipcode": "0283"
  },
  "PHO.OL": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "NOK",
    "exchange": "OSL",
    "industry": "Drug Manufacturers - Specialty & Generic",
    "long_name": "Photocure ASA",
    "market": "no_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "PHOTOCURE ASA",
    "state": null,
    "summary": "Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, pharmacies, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway.",
    "website": "http://www.photocure.com",
    "zipcode": "0275"
  },
  "PHS.F": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Drug Manufacturers - Specialty & Generic",
    "long_name": "Photocure ASA",
    "market": "dr_market",
    "market_cap": "Small Cap",
    "sector": "Healthcare",
    "short_name": "PHOTOCURE ASA  NK-,50",
    "state": null,
    "summary": "Photocure ASA, a specialty pharmaceutical company, engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in Nordic countries, Germany, France, Austria, the United Kingdom, the Netherlands, other European Countries, and the United States. The company offers Hexvix/Cysview for the detection and management of bladder cancer. It also develops Cevira for the treatment of human papilloma virus infection and precancerous lesions of the cervix. The company sells its products to license partners, pharmaceutical wholesalers, pharmacies, and hospitals. Photocure ASA was founded in 1997 and is headquartered in Oslo, Norway.",
    "website": "http://www.photocure.com",
    "zipcode": "0275"
  },
  "VISTN.OL": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "NOK",
    "exchange": "OSL",
    "industry": "Drug Manufacturers - Specialty & Generic",
    "long_name": "Vistin Pharma ASA",
    "market": "no_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "VISTIN PHARMA ASA",
    "state": null,
    "summary": "Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.",
    "website": "http://www.vistin.com",
    "zipcode": "0661"
  },
  "VP4.F": {
    "city": "Oslo",
    "country": "Norway",
    "currency": "EUR",
    "exchange": "FRA",
    "industry": "Drug Manufacturers - Specialty & Generic",
    "long_name": "Vistin Pharma ASA",
    "market": "dr_market",
    "market_cap": "Micro Cap",
    "sector": "Healthcare",
    "short_name": "VISTIN PHARMA ASA  NK 1",
    "state": null,
    "summary": "Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin APIs and direct compressive granulates for the pharmaceutical industry. The company was incorporated in 2015 and is headquartered in Oslo, Norway.",
    "website": "http://www.vistin.com",
    "zipcode": "0661"
  }
}
